Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Assets: 2019-2025

Historic Assets for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $105.2 million.

  • Benitec Biopharma's Assets rose 601.44% to $105.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $105.2 million, marking a year-over-year increase of 601.44%. This contributed to the annual value of $52.2 million for FY2024, which is 1069.58% up from last year.
  • As of Q1 2025, Benitec Biopharma's Assets stood at $105.2 million, which was up 33.06% from $79.1 million recorded in Q4 2024.
  • In the past 5 years, Benitec Biopharma's Assets registered a high of $105.2 million during Q1 2025, and its lowest value of $4.5 million during Q2 2023.
  • Its 3-year average for Assets is $42.4 million, with a median of $27.1 million in 2023.
  • Its Assets has fluctuated over the past 5 years, first crashed by 72.06% in 2022, then surged by 1,069.58% in 2024.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Assets stood at $14.0 million in 2021, then decreased by 15.05% to $11.9 million in 2022, then soared by 79.36% to $21.4 million in 2023, then skyrocketed by 270.29% to $79.1 million in 2024, then soared by 601.44% to $105.2 million in 2025.
  • Its Assets stands at $105.2 million for Q1 2025, versus $79.1 million for Q4 2024 and $68.8 million for Q3 2024.